Getinib 250 Mg (Gefitinib) – 30 Tablets

Getinib 250 mg is used for the patients with advanced non-small cell lung cancer (NSCLC) that hase spread. It is intended for patients whose tumors have specific mutations in the epidermal growth factor receptor (EGFR).